Rachel A Stahler is Chief Information Officer of Organon & Co.. Currently has a direct ownership of 50,186 shares of OGN, which is worth approximately $849,147. The most recent transaction as insider was on Sep 03, 2024, when has been sold 1,645 shares (Common Stock) at a price of $20.35 per share, resulting in proceeds of $33,475. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.2K
4.04% 3M change
57.91% 12M change
Total Value Held $849,147

Rachel A Stahler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2024
SELL
Payment of exercise price or tax liability
$33,475 $20.35 p/Share
1,645 Reduced 3.17%
50,186 Common Stock
Sep 03 2024
BUY
Grant, award, or other acquisition
-
3,594 Added 6.48%
51,831 Common Stock
May 04 2024
SELL
Payment of exercise price or tax liability
$20,492 $19.61 p/Share
1,045 Reduced 2.12%
48,237 Common Stock
May 04 2024
BUY
Exercise of conversion of derivative security
-
3,049 Added 5.83%
49,282 Common Stock
Mar 31 2024
SELL
Payment of exercise price or tax liability
$65,254 $18.8 p/Share
3,471 Reduced 6.98%
46,233 Common Stock
Mar 31 2024
BUY
Grant, award, or other acquisition
-
10,132 Added 17.29%
48,478 Common Stock
Feb 28 2024
SELL
Payment of exercise price or tax liability
$78,041 $18.04 p/Share
4,326 Reduced 9.85%
39,572 Common Stock
Feb 28 2024
BUY
Exercise of conversion of derivative security
-
12,117 Added 21.63%
43,898 Common Stock
Aug 05 2023
SELL
Payment of exercise price or tax liability
$95,119 $21.53 p/Share
4,418 Reduced 12.2%
31,781 Common Stock
Aug 05 2023
BUY
Exercise of conversion of derivative security
-
12,895 Added 26.27%
36,199 Common Stock
May 04 2023
SELL
Payment of exercise price or tax liability
$25,306 $24.24 p/Share
1,044 Reduced 4.29%
23,304 Common Stock
May 04 2023
BUY
Exercise of conversion of derivative security
-
3,046 Added 11.12%
24,348 Common Stock
Mar 31 2023
SELL
Payment of exercise price or tax liability
$28,308 $23.09 p/Share
1,226 Reduced 5.44%
21,302 Common Stock
Mar 31 2023
BUY
Exercise of conversion of derivative security
-
3,578 Added 13.71%
22,528 Common Stock
Aug 05 2022
SELL
Payment of exercise price or tax liability
$143,123 $32.41 p/Share
4,416 Reduced 18.9%
18,950 Common Stock
Aug 05 2022
BUY
Exercise of conversion of derivative security
-
12,890 Added 35.55%
23,366 Common Stock
May 04 2022
SELL
Payment of exercise price or tax liability
$33,867 $32.44 p/Share
1,044 Reduced 9.06%
10,476 Common Stock
May 04 2022
BUY
Exercise of conversion of derivative security
-
3,046 Added 20.91%
11,520 Common Stock
Aug 05 2021
SELL
Payment of exercise price or tax liability
$126,430 $28.63 p/Share
4,416 Reduced 34.26%
8,474 Common Stock
Aug 05 2021
BUY
Exercise of conversion of derivative security
$369,041 $28.63 p/Share
12,890 Added 50.0%
12,890 Common Stock

Also insider at

NEO
NEOGENOMICS INC Healthcare
RAS

Rachel A Stahler

Chief Information Officer
Jersey City,, NJ

Track Institutional and Insider Activities on OGN

Follow Organon & Co. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OGN shares.

Notify only if

Insider Trading

Get notified when an Organon & Co. insider buys or sells OGN shares.

Notify only if

News

Receive news related to Organon & Co.

Track Activities on OGN